Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
1.020
+0.031 (3.18%)
Nov 22, 2024, 4:00 PM EST - Market closed

Rallybio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-66.97-74.56-66.65-47.01-26.45-17.56
Depreciation & Amortization
0.140.150.170.110.060.03
Loss (Gain) From Sale of Investments
-1.95-3.09-0.44---
Loss (Gain) on Equity Investments
2.422.041.081.511.520.1
Stock-Based Compensation
8.5810.929.53.650.70.19
Other Operating Activities
-----0.14
Change in Accounts Payable
0.13-0.10.49-0.980.720.73
Change in Other Net Operating Assets
5.54.38-1.42-2.81.41.34
Operating Cash Flow
-51.07-60.27-57.28-45.53-22.04-15.03
Capital Expenditures
-0.01-0.01-0.05-0.33-0.14-0.19
Investment in Securities
51.9927.67-112.12-2-1.94-
Investing Cash Flow
51.9727.66-112.17-2.33-2.07-0.19
Issuance of Common Stock
5.520.2851.7786.2145.21-
Other Financing Activities
-0.27-0.14-0.69-3.23-0.32-0.03
Financing Cash Flow
5.250.1451.0882.97144.8931.57
Net Cash Flow
6.16-32.46-118.3835.1120.7816.35
Free Cash Flow
-51.08-60.28-57.34-45.87-22.18-15.21
Free Cash Flow Per Share
-1.20-1.49-1.80-1.80-1.28-8.87
Levered Free Cash Flow
-26.26-34.15-33.77-28.91-12.75-
Unlevered Free Cash Flow
-26.26-34.15-33.77-28.91-12.71-
Change in Net Working Capital
-6.72-4.120.963.8-2.47-
Source: S&P Capital IQ. Standard template. Financial Sources.